Ocular Therapeutix (OCUL) Other Working Capital Changes (2019 - 2026)
Ocular Therapeutix (OCUL) posted quarterly Other Working Capital Changes of -$812000.0 for Q2 2026, down 7481.82% year-over-year from $11000.0 in Q2 2025, and down 145.93% on a QoQ basis from $1.8 million in Q1 2026.
Ocular Therapeutix (OCUL) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Ocular Therapeutix has reported Other Working Capital Changes for 8 years, with the latest figure at -$812000.0 in Q2 2026.
- Other Working Capital Changes for Q2 2026 came in at -$812000.0, down 7481.82% year-over-year; the trailing twelve-month figure through Jun 2026 was -$445000.0 (up 38.45% YoY), and the FY2025 annual result was -$1.6 million, down 38.79% from the prior year.
- Other Working Capital Changes slipped to -$812000.0 in Q2 2026, from $1.8 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $7.0 million in Q3 2024 and troughed at -$3.9 million in Q1 2025.
- A 5-year average of $386000.0 and a median of $94000.0 in 2022 frame the typical range for Other Working Capital Changes.
- The largest YoY upside for Other Working Capital Changes was 790.62% in 2026 against a maximum downside of 7481.82% in 2026.
- A 5-year view of Other Working Capital Changes shows it stood at $1.6 million in 2022, then slumped by 141.75% to -$665000.0 in 2023, then jumped by 95.34% to -$31000.0 in 2024, then sank by 2348.39% to -$759000.0 in 2025, then declined by 6.98% to -$812000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$812000.0 in Q2 2026, $1.8 million in Q1 2026, and -$759000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ocular Therapeutix | 2.20 Bn | 2.20 Bn | 11.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -812,000.00 |
| Jun 30, 2026 | -812,000.00 |
| Jun 30, 2026 | -812,000.00 |
| Mar 31, 2026 | 1.77 Mn |
| Mar 31, 2026 | 1.77 Mn |
| Mar 31, 2026 | 1.77 Mn |
| Jun 30, 2025 | 128,000.00 |
| Jun 30, 2025 | 128,000.00 |
| Jun 30, 2025 | 128,000.00 |
| Mar 31, 2025 | -256,000.00 |
| Mar 31, 2025 | -256,000.00 |
| Mar 31, 2025 | -256,000.00 |
| Dec 31, 2024 | 893,000.00 |
| Dec 31, 2024 | 893,000.00 |
| Dec 31, 2024 | 893,000.00 |
| Sep 30, 2024 | -447,000.00 |
| Sep 30, 2024 | -447,000.00 |
| Sep 30, 2024 | -447,000.00 |
| Jun 30, 2024 | -649,000.00 |
| Jun 30, 2024 | -649,000.00 |